Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Optical Imaging | 10 | 2021 | 77 | 3.130 |
Why?
|
| Skin Neoplasms | 14 | 2020 | 408 | 3.100 |
Why?
|
| Methylene Blue | 11 | 2024 | 23 | 2.400 |
Why?
|
| Microscopy, Confocal | 7 | 2015 | 240 | 1.950 |
Why?
|
| Fluorescence Polarization | 5 | 2024 | 32 | 1.590 |
Why?
|
| Skin | 6 | 2021 | 422 | 1.450 |
Why?
|
| Brain Neoplasms | 4 | 2015 | 318 | 1.260 |
Why?
|
| Microscopy, Polarization | 5 | 2018 | 7 | 1.110 |
Why?
|
| Breast Neoplasms | 4 | 2021 | 1222 | 1.080 |
Why?
|
| Microscopy, Fluorescence | 5 | 2021 | 401 | 1.060 |
Why?
|
| Terahertz Imaging | 3 | 2016 | 11 | 0.950 |
Why?
|
| Coloring Agents | 5 | 2012 | 50 | 0.900 |
Why?
|
| Low-Level Light Therapy | 3 | 2023 | 11 | 0.900 |
Why?
|
| Demeclocycline | 2 | 2015 | 4 | 0.880 |
Why?
|
| Mohs Surgery | 4 | 2020 | 54 | 0.870 |
Why?
|
| Contrast Media | 4 | 2015 | 432 | 0.870 |
Why?
|
| Multimodal Imaging | 2 | 2016 | 73 | 0.870 |
Why?
|
| Optics and Photonics | 3 | 2021 | 13 | 0.840 |
Why?
|
| Stomatitis | 1 | 2023 | 8 | 0.820 |
Why?
|
| Thyroid Neoplasms | 1 | 2024 | 87 | 0.790 |
Why?
|
| Skin Physiological Phenomena | 2 | 2021 | 16 | 0.690 |
Why?
|
| Light | 2 | 2021 | 195 | 0.680 |
Why?
|
| Collagen | 3 | 2018 | 135 | 0.670 |
Why?
|
| Temperature | 1 | 2021 | 316 | 0.610 |
Why?
|
| Image Enhancement | 2 | 2012 | 194 | 0.550 |
Why?
|
| Carcinoma, Squamous Cell | 4 | 2020 | 261 | 0.540 |
Why?
|
| Glioma | 2 | 2015 | 101 | 0.500 |
Why?
|
| Head and Neck Neoplasms | 1 | 2017 | 166 | 0.460 |
Why?
|
| Lasers, Semiconductor | 1 | 2015 | 3 | 0.460 |
Why?
|
| Skin Aging | 1 | 2015 | 11 | 0.460 |
Why?
|
| Cosmetic Techniques | 1 | 2015 | 13 | 0.460 |
Why?
|
| Biomarkers, Tumor | 1 | 2019 | 524 | 0.450 |
Why?
|
| Mitochondria | 1 | 2019 | 410 | 0.440 |
Why?
|
| Sensitivity and Specificity | 6 | 2016 | 1163 | 0.430 |
Why?
|
| Neoplasms | 2 | 2023 | 1368 | 0.430 |
Why?
|
| Margins of Excision | 3 | 2020 | 31 | 0.420 |
Why?
|
| Humans | 29 | 2024 | 65140 | 0.410 |
Why?
|
| Monte Carlo Method | 3 | 2023 | 98 | 0.380 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2012 | 44 | 0.370 |
Why?
|
| Molecular Imaging | 1 | 2012 | 52 | 0.360 |
Why?
|
| Lasers | 2 | 2009 | 37 | 0.340 |
Why?
|
| Equipment Design | 5 | 2012 | 363 | 0.340 |
Why?
|
| Carcinoma | 1 | 2012 | 130 | 0.340 |
Why?
|
| Feasibility Studies | 4 | 2021 | 587 | 0.340 |
Why?
|
| Tetracycline | 2 | 2009 | 22 | 0.320 |
Why?
|
| Tomography, Optical Coherence | 1 | 2012 | 235 | 0.310 |
Why?
|
| Aged | 9 | 2020 | 14965 | 0.290 |
Why?
|
| Dysplastic Nevus Syndrome | 1 | 2009 | 2 | 0.290 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2024 | 699 | 0.290 |
Why?
|
| Middle Aged | 10 | 2020 | 18273 | 0.280 |
Why?
|
| Female | 12 | 2021 | 34018 | 0.280 |
Why?
|
| Melanoma | 2 | 2009 | 333 | 0.270 |
Why?
|
| Pilot Projects | 5 | 2018 | 1015 | 0.260 |
Why?
|
| Spectrophotometry, Infrared | 1 | 2006 | 25 | 0.250 |
Why?
|
| Reproducibility of Results | 4 | 2015 | 1698 | 0.240 |
Why?
|
| Adult | 8 | 2020 | 17358 | 0.240 |
Why?
|
| Aged, 80 and over | 5 | 2020 | 5614 | 0.230 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2007 | 187 | 0.220 |
Why?
|
| Staining and Labeling | 4 | 2007 | 127 | 0.220 |
Why?
|
| Male | 12 | 2020 | 31047 | 0.220 |
Why?
|
| Cytodiagnosis | 1 | 2024 | 46 | 0.210 |
Why?
|
| Thyroid Gland | 1 | 2024 | 83 | 0.200 |
Why?
|
| Disease Models, Animal | 3 | 2010 | 2293 | 0.200 |
Why?
|
| Radiometry | 1 | 2023 | 39 | 0.200 |
Why?
|
| Intraoperative Period | 2 | 2012 | 34 | 0.190 |
Why?
|
| Tolonium Chloride | 3 | 2007 | 3 | 0.170 |
Why?
|
| Brain | 3 | 2015 | 1605 | 0.170 |
Why?
|
| Thermal Conductivity | 1 | 2021 | 5 | 0.170 |
Why?
|
| Equipment Failure Analysis | 2 | 2012 | 78 | 0.170 |
Why?
|
| Scattering, Radiation | 1 | 2021 | 72 | 0.160 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 1565 | 0.160 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 868 | 0.150 |
Why?
|
| In Vitro Techniques | 3 | 2011 | 491 | 0.140 |
Why?
|
| Immunohistochemistry | 3 | 2016 | 896 | 0.140 |
Why?
|
| Wound Healing | 2 | 2010 | 193 | 0.130 |
Why?
|
| Adipose Tissue | 2 | 2012 | 299 | 0.130 |
Why?
|
| Diagnosis, Differential | 2 | 2012 | 991 | 0.130 |
Why?
|
| Sampling Studies | 1 | 2016 | 65 | 0.120 |
Why?
|
| Biopsy, Needle | 1 | 2016 | 134 | 0.120 |
Why?
|
| Rejuvenation | 1 | 2015 | 3 | 0.120 |
Why?
|
| Laser Therapy | 2 | 2006 | 40 | 0.120 |
Why?
|
| Pituitary Neoplasms | 1 | 2015 | 21 | 0.110 |
Why?
|
| Fluorescent Dyes | 2 | 2015 | 202 | 0.110 |
Why?
|
| Radionuclide Imaging | 1 | 2015 | 128 | 0.110 |
Why?
|
| Meningeal Neoplasms | 1 | 2015 | 62 | 0.110 |
Why?
|
| Meningioma | 1 | 2015 | 63 | 0.110 |
Why?
|
| Brain Chemistry | 1 | 2014 | 76 | 0.110 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 222 | 0.100 |
Why?
|
| Mice | 3 | 2021 | 11119 | 0.100 |
Why?
|
| Glioblastoma | 1 | 2015 | 161 | 0.100 |
Why?
|
| Fibroblasts | 2 | 2012 | 422 | 0.090 |
Why?
|
| Rose Bengal | 2 | 2010 | 7 | 0.090 |
Why?
|
| Animals | 6 | 2021 | 21345 | 0.090 |
Why?
|
| Biopsy | 1 | 2012 | 456 | 0.080 |
Why?
|
| Models, Statistical | 1 | 2012 | 309 | 0.080 |
Why?
|
| Dermatitis, Phototoxic | 1 | 2010 | 2 | 0.080 |
Why?
|
| Tissue Adhesives | 1 | 2010 | 7 | 0.080 |
Why?
|
| Dermatologic Surgical Procedures | 1 | 2010 | 35 | 0.080 |
Why?
|
| Biomarkers | 1 | 2015 | 1480 | 0.080 |
Why?
|
| Chromogenic Compounds | 1 | 2009 | 1 | 0.070 |
Why?
|
| Dermatology | 1 | 2010 | 65 | 0.070 |
Why?
|
| Aging | 1 | 2015 | 771 | 0.070 |
Why?
|
| Cell Nucleus | 1 | 2012 | 630 | 0.070 |
Why?
|
| Time Factors | 1 | 2015 | 3762 | 0.060 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 2701 | 0.060 |
Why?
|
| Dermis | 1 | 2006 | 22 | 0.060 |
Why?
|
| Phototherapy | 1 | 2006 | 33 | 0.060 |
Why?
|
| Achilles Tendon | 1 | 2005 | 8 | 0.060 |
Why?
|
| Port-Wine Stain | 1 | 2005 | 10 | 0.060 |
Why?
|
| Tendon Injuries | 1 | 2005 | 16 | 0.060 |
Why?
|
| Young Adult | 1 | 2015 | 4809 | 0.050 |
Why?
|
| Photochemotherapy | 1 | 2005 | 46 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 1 | 2010 | 3485 | 0.050 |
Why?
|
| Swine | 2 | 2010 | 394 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 1113 | 0.030 |
Why?
|
| Skin Absorption | 1 | 2010 | 16 | 0.020 |
Why?
|
| Photosensitizing Agents | 1 | 2010 | 32 | 0.020 |
Why?
|
| Random Allocation | 1 | 2010 | 200 | 0.020 |
Why?
|
| Reference Values | 1 | 2010 | 327 | 0.020 |
Why?
|
| Rabbits | 1 | 2010 | 338 | 0.020 |
Why?
|
| Cell Survival | 1 | 2010 | 587 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2007 | 51 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2007 | 185 | 0.020 |
Why?
|
| Electrons | 1 | 2006 | 33 | 0.020 |
Why?
|
| Glucose | 1 | 2010 | 476 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2007 | 602 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2010 | 2188 | 0.010 |
Why?
|
| Rupture | 1 | 2005 | 24 | 0.010 |
Why?
|
| Tensile Strength | 1 | 2005 | 32 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2005 | 624 | 0.010 |
Why?
|
| Rats | 1 | 2005 | 1994 | 0.010 |
Why?
|
| Risk Factors | 1 | 2010 | 5429 | 0.010 |
Why?
|
| Adolescent | 1 | 2005 | 6297 | 0.010 |
Why?
|